NEWS: The US_FDA has issued a notice of proposed rulemaking (NPRM) that, if finalized, would allow for the importation of certain prescription drugs from Canada.
. In addition, the Administration is announcing the availability of a new draft guidance for industry that describes procedures drug manufacturers can follow to facilitate importation of prescription drugs, including biological products, that are FDA-approved, manufactured abroad, authorized for sale in any foreign country, and originally intended for sale in that foreign country.
“Today’s announcement outlines two pathways for the safe importation of certain prescription drugs to help provide safe, effective, more affordable drugs to American patients,” said Health and Human Services Secretary Alex Azar. “These are historic actions by HHS and the FDA, and they represent the bold nature of President Trump’s agenda for lowering drug costs.
“The FDA continues to assess and act on multiple opportunities to promote competition that can, in turn, help reduce drug prices and improve access to medicines for Americans,” said Assistant Secretary for Health Brett Giroir. “The proposed rule and draft guidance include procedures intended to protect the public’s health and safety. We look forward to receiving public comment on these draft policies, and we will take timely comments into account as we work to finalize the rule and guidance.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Trump administration downplays Mexican concerns about key piece of USMCA trade dealRobert Lighthizer said language in the United States-Mexico-Canada Agreement does not call for American 'labor inspectors' in Mexico.
Consulte Mais informação »
Trump Administration Proposes New Rules to Increase Accountability and Availability of the Organ SupplyThe U.S. Department of Health and Human Services (HHS) today took major steps to increase the availability of organs for the 113,000 Americans on waitlists for lifesaving organ transplants – 20 of whom die each day. As directed by President Trump in his July 10 Executive Order on Advancing American Kidney Health, the Centers for Medicare & Medicaid Services (CMS) is issuing a proposed rule to change the way organ procurement organizations (OPOs) are held accountable for their performance, and the Health Resources and Services Administration (HRSA) is issuing a proposed rule to remove financial barriers to living organ donation.
Consulte Mais informação »
Trump administration to stick with 2020 biofuel plan over farmer objections - sourcesThe White House will stick with its current proposal on 2020 biofuel blending requirements, despite anger in Farm Country that the plan does too little for corn growers, according to two sources familiar with the matter. The issue could undermine President Donald Trump&39;s support among biofuel advocates
Consulte Mais informação »
Trump Administration Extends Deadline for Affordable Care Act EnrollmentPeople will have more time to sign up for health coverage on the federal Affordable Care Act exchange after some experienced problems using the website Sunday, Trump administration officials said.
Consulte Mais informação »
Trump administration seeks to make more kidneys available for transplantsThe Trump administration announced a proposed change to rules it hopes will radically transform the kidney donation system in the United States, resulting in 5,000 more organ transplants a year
Consulte Mais informação »